QRX-007

N/A

Report date: 2022/08/29 14:03:47

Base Information

Drug NameQRX-007
Drug Alias NameQRX-007
ClassificationBiologics > Protein drugs
Mechanisms of ActionKallikrein-5 inhibitorsKallikrein-7 inhibitors
TargetsKallikrein-5Kallikrein-7
Therapy Area/IndicationsNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuoin Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQuoin Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A